Cargando…

Multiple Myeloma in a Patient with Acromegaly

Acromegaly is a slowly progressing condition resulting from excess growth hormone (GH), generally caused by a GH-secreting pituitary adenoma. Cancer is the third most common cause of mortality in patients with acromegaly, and insulin-like growth factor 1 (IGF-1) is known to influence tumor formation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Yu Mi, Choi, Jong Han, Lee, Min Jung, Ahn, Ari, Park, Chan-Jeoung, Chang, Kiju, Seo, Seyoung, Hong, Sun In, Kim, Min-Seon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384674/ https://www.ncbi.nlm.nih.gov/pubmed/25491781 http://dx.doi.org/10.3803/EnM.2015.30.1.110

Ejemplares similares

Auer rod-like crystal inclusions in plasma cells of multiple myeloma
por: Oh, Sung-hee, et al.
Publicado: (2010)

Two Rare Cases of Therapy-Related Acute Lymphoblastic Leukemia in Patients With Plasma Cell Myeloma
por: Lee, Hye-Young, et al.
Publicado: (2019)

The immune checkpoint molecule V-set Ig domain-containing 4 is an independent prognostic factor for multiple myeloma
por: Roh, Jin, et al.
Publicado: (2017)

The risk factors for herpes zoster in bortezomib treatment in patients with multiple myeloma
por: Yi, Yang-Seon, et al.
Publicado: (2010)

Multiple facets in the control of acromegaly
por: Vilar, Lucio, et al.
Publicado: (2013)

Multiple Myeloma with Biclonal Gammopathy Accompanied by Prostate Cancer
por: Kim, Nae Yu, et al.
Publicado: (2011)

Crystalline podocytopathy and tubulopathy without overt glomerular proteinuria in a patient with multiple myeloma
por: Lee, Eun Jeong, et al.
Publicado: (2016)

Expression of CD99 in Multiple Myeloma: A Clinicopathologic and Immunohistochemical Study of 170 Cases
por: Shin, Su-Jin, et al.
Publicado: (2014)

Bone Cement Augmentation Procedures for Spinal Pathologic Fractures by Multiple Myeloma
por: Ha, Kee-Yong, et al.
Publicado: (2015)

Increased Monocytic Myeloid-Derived Suppressor Cells in Whole Blood Predict Poor Prognosis in Patients with Plasma Cell Myeloma
por: Bae, Mi-Hyun, et al.
Publicado: (2021)

Oliguria as an early indicator of mortality risk in patients with multiple myeloma and renal impairment
por: Jung, Sung-Hoon, et al.
Publicado: (2015)

Advantage of achieving deep response following frontline daratumumab-VTd compared to VRd in transplant-eligible multiple myeloma: multicenter study
por: Byun, Ja Min, et al.
Publicado: (2023)

Pseudohyperphosphatemia in a Patient with Multiple Myeloma
por: Lee, Yonggu, et al.
Publicado: (2007)

Serum Parathyroid Hormone Is a New Potential Risk Factor in Multiple Myeloma
por: Kang, Min-Gu, et al.
Publicado: (2014)

Common and different alterations of bone marrow mesenchymal stromal cells in myelodysplastic syndrome and multiple myeloma
por: Choi, Hayoung, et al.
Publicado: (2020)

Multiple Myeloma Presenting as a Testicular Mass
por: Kang, Min Jong, et al.
Publicado: (1994)

Frontline therapy for newly diagnosed patients with multiple myeloma
por: Jung, Sung-Hoon, et al.
Publicado: (2020)

Acromegaly
por: Chanson, Philippe, et al.
Publicado: (2008)

Acromegaly
Publicado: (1932)

Acromegaly
por: Gibson, G. A.
Publicado: (1899)

Acromegaly
Publicado: (1890)

Prevalence and Risk Factors for Adrenal Insufficiency in Patients with Multiple Myeloma Receiving Long-Term Chemotherapy including Corticosteroids: A Retrospective Cohort Study
por: Yoon, Jee Hee, et al.
Publicado: (2021)

Emphysematous osteomyelitis due to Escherichia coli in multiple myeloma
por: Park, Sung Soo, et al.
Publicado: (2016)

Single-cell analysis of multiple myelomas refines the molecular features of bortezomib treatment responsiveness
por: Jung, Seung-Hyun, et al.
Publicado: (2022)

Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement
por: Chin, Sang Ouk, et al.
Publicado: (2019)

Crohn's disease and smoldering multiple myeloma: a case report and literature review
por: Park, So Young, et al.
Publicado: (2017)

Predictive Value of Post-Transplant Bone Marrow Plasma Cell Percent in Multiple Myeloma Patients Undergone Autologous Transplantation
por: Hwang, In Hye, et al.
Publicado: (2011)

Immune Checkpoint Programmed Cell Death Protein-1 (PD-1) Expression on Bone Marrow T Cell Subsets in Patients With Plasma Cell Myeloma
por: Lee, Min Young, et al.
Publicado: (2021)

Tumorigenesis of Papillary Thyroid Cancer Is Not BRAF-Dependent in Patients with Acromegaly
por: Kim, Hee Kyung, et al.
Publicado: (2014)

Clinical Outcome of Bortezomib Retreatment in Patients with Relapsed or Refractory Multiple Myeloma
por: Ahn, Jae-Sook, et al.
Publicado: (2014)

A Case of Nonsecretory Multiple Myeloma with Atypical Imaging Features
por: Lee, Hwa Yeon, et al.
Publicado: (2006)

Cerebral Infarction in IgG Multiple Myeloma with Hyperviscosity
por: Park, Man-Seok, et al.
Publicado: (2005)

Rapid Progression of Solitary Plasmacytoma to Multiple Myeloma in Lumbar Vertebra
por: Yang, Jin Seo, et al.
Publicado: (2013)

Cutaneous comorbidities in patients with multiple myeloma: A 10-year retrospective cohort study from a Korean population
por: Woo, Yu Ri, et al.
Publicado: (2018)

Clinical impact of echocardiography-defined pulmonary hypertension on the clinical outcome in patients with multiple myeloma
por: Bae, SungA, et al.
Publicado: (2020)

Management of acromegaly
por: Vasilev, Vladimir, et al.
Publicado: (2010)

Localized acromegaly
por: Palikhe, Gaurav, et al.
Publicado: (2012)

Acromegaly in pregnancy
por: Koshy, T. George, et al.
Publicado: (2012)

Essays on Acromegaly
Publicado: (1892)

The Endothelium in Acromegaly
por: Maffei, Pietro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sorq6lgfkvjfeijr8l7o7ebfdt